Get started
Author

Keisuke Oda

ORCID: 0000-0002-3230-4901
Observed ORCID: 0000-0002-3230-4901
OpenAlex ID: A5014929401
Sodium butyrate abolishes lipopolysaccharide-induced depression-like behaviors and hippocampal microglial activation in mice
2017 · Yosuke Yamawaki, Norika Yoshioka, et al. · Brain Research · 211
Citrus limon L.-Derived Nanovesicles Show an Inhibitory Effect on Cell Growth in p53-Inactivated Colorectal Cancer Cells via the Macropinocytosis Pathway
2022 · Hideki Takakura, Toshimasa Nakao, et al. · Biomedicines · 63
Endocytic Uptake of FITC-albumin by Human Alveolar Epithelial Cell Line A549
2012 · Ryoko Yumoto, Sayuri Suzuka, et al. · Drug Metabolism and Pharmacokinetics · 63
Four New Iridoid Glucosides from Ajuga reptans
2011 · Masateru Ono, Chisato Furusawa, et al. · Chemical and Pharmaceutical Bulletin · 29
PDF
Low-Affinity Transport of FITC-Albumin in Alveolar Type II Epithelial Cell Line RLE-6TN
2008 · Maki Tagawa, Ryoko Yumoto, et al. · Drug Metabolism and Pharmacokinetics · 27
Mechanism underlying insulin uptake in alveolar epithelial cell line RLE-6TN
2011 · Keisuke Oda, Ryoko Yumoto, et al. · European Journal of Pharmacology · 24
Discovery of Orally Active and Nonsteroidal Farnesoid X Receptor (FXR) Antagonist with Propensity for Accumulation and Responsiveness in Ileum
2021 · Naoki Teno, Yusuke Iguchi, et al. · ACS Medicinal Chemistry Letters · 22
Comparison of Berberine Bioavailability between Oral and Rectal Administrations in Rats
2023 · Nobuhiro Mori, Keisuke Oda, et al. · Biological and Pharmaceutical Bulletin · 15
PDF
Discovery of FXR/PPARγ dual partial agonist
2023 · Yukiko Yamashita, Keigo Gohda, et al. · Bioorganic & Medicinal Chemistry · 14
N1-Substituted benzimidazole scaffold for farnesoid X receptor (FXR) agonists accompanying prominent selectivity against vitamin D receptor (VDR)
2020 · Arisa Masuda, Keigo Gohda, et al. · Bioorganic & Medicinal Chemistry · 12
Identification of potent farnesoid X receptor (FXR) antagonist showing favorable PK profile and distribution toward target tissues: Comprehensive understanding of structure-activity relationship of FXR antagonists
2019 · Naoki Teno, Yukiko Yamashita, et al. · Bioorganic & Medicinal Chemistry · 12
Study on the infusion‑site adverse events and vascular distribution of epirubicin in chemotherapy with epirubicin and fosaprepitant
2019 · Miho Yamasaki, Ryuji Kimura, et al. · Molecular and Clinical Oncology · 10
PDF
Pharmacokinetic interaction of green tea beverage containing cyclodextrins and high concentration catechins with P-glycoprotein substrates in LLC-GA5-COL150 cells in vitro and in the small intestine of rats in vivo
2017 · Keisuke Oda, Teruo Murakami · Journal of Pharmacy and Pharmacology · 9
【Original Contribution】 Introduction of a Single Transporter Gene ABCA3 Directs RLE-6TN to More Type II-like Alveolar Epithelial Cells
2013 · Mikihisa Takano, Chieko Yamamoto, et al. · MEMBRANE · 8
PDF
FXR Antagonist FLG249 Lowers Hepatic Triacylglycerol and Serum Cholesterol Level in High-Fat Diet-Induced Obese Mice
2024 · Yusuke Iguchi, Yukiko Yamashita, et al. · Biological and Pharmaceutical Bulletin · 6
PDF
Enhancement Effect of Poly(amino acid)s on Insulin Uptake in Alveolar Epithelial Cells
2012 · Keisuke Oda, Ryoko Yumoto, et al. · Drug Metabolism and Pharmacokinetics · 6
Modulation of multidrug resistance-associated proteins function in erythrocytes in glycerol-induced acute renal failure rats
2016 · Aoi Matsushima, Keisuke Oda, et al. · Journal of Pharmacy and Pharmacology · 4
Modulation of P-glycoprotein Expression and Function under Disease States in Rats and Humans
2017 · Teruo Murakami, Masashi Ishiguro, et al. · International Journal of Clinical Pharmacology & Pharmacotherapy · 3
PDF
Uptake and metabolism of mizoribine, an immunosuppressant, in L5178Y-R mouse lymphoma cells in vitro and peripheral blood mononuclear cells of rats and kidney transplant recipients in vivo
2018 · Keisuke Oda, Nobuhiro Mori, et al. · Drug Metabolism and Pharmacokinetics · 2
Small RNA sequencing analysis identified miR159a as a novel candidate for activity in plant-derived nanovesicles from limon, hassaku, and sudachi
2026 · Hideki Takakura, Shingo Miyamoto, et al. · Scientific Reports · 1
PDF
Elucidation of Desensitization Mechanisms Induced by Oral Immunotherapy in a Rat Model of Ovalbumin Allergy
2025 · Daigo Takizawa, Tomoharu Yokooji, et al. · Foods · 1
PDF
Study on the method to avoid infusion‑site adverse events following chemotherapeutic treatment with epirubicin and fosaprepitant using immortalized human umbilical vein endothelial cells
2022 · Miho Yamasaki, Keisuke Oda, et al. · Oncology Letters · 1
PDF
Biopharmaceutical Properties of Tubeimoside-1: A Cytotoxic Amphipathic Cyclic Bisdesmoside
2017 · Keisuke Oda, Tomomi Umakoshi, et al. · International Journal of Clinical Pharmacology & Pharmacotherapy · 1
PDF
Multifactorial Alterations in Lacosamide Exposure in an Elderly Woman with Symptomatic Epilepsy and Tuberculous Pleurisy: A Case Report
2025 · Ryo Takeda, Shohei Matsuda, et al. · Biological and Pharmaceutical Bulletin
PDF
Mechanism underlying infusion-site adverse events induced by anthracycline and fosaprepitant
2021 · Keisuke Oda · The Pharmaceutical Society of Japan
Works count: 26
Citation count: 544
H-index: 11
I10-index: 12
Year
Topic
Type